✦ LIBER ✦

Prediction of Major Vascular Events after Stroke: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial

✍ Scribed by Ovbiagele, Bruce; Goldstein, Larry B.; Amarenco, Pierre; Messig, Michael; Sillesen, Henrik; Callahan, Alfred; Hennerici, Michael G.; Zivin, Justin; Welch, K.Michael A.

Book ID: 122244285
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 130 KB
Volume: 23
Category: Article
ISSN: 1532-8511
DOI: 10.1016/j.jstrokecerebrovasdis.2013.12.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemorrhagic stroke in the Stroke Prevent

Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study

✍ Goldstein, L. B.; Amarenco, P.; Szarek, M.; Callahan, A.; Hennerici, M.; Sillese 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 527 KB

Ischemic stroke: A cardiovascular risk e

Ischemic stroke: A cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

✍ David H. Fitchett; Shaun G. Goodman; Anatoly Langer 📂 Article 📅 2008 🏛 Pulsus Group Inc 🌐 English ⚖ 613 KB

High-Dose Atorvastatin After Stroke or T

High-Dose Atorvastatin After Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators

✍ Jocelyne G. Karam; Lisel Loney-Hutchinson; Samy I. McFarlane 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 91 KB

Design and Baseline Characteristics of t

Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

📂 Article 📅 2003 🏛 S. Karger AG 🌐 English ⚖ 115 KB

Baseline blood pressure, low- and high-d

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

✍ Pierre Amarenco; Larry B. Goldstein; Alfred Callahan III; Henrik Sillesen; Micha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 203 KB

High-dose atorvastatin and risk of atria

High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

✍ Gregory G. Schwartz; Bernard R. Chaitman; Jeffrey J. Goldberger; Michael Messig 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB